Veniti (Saint Louis, MO) a development-stage medical device company focused on iliac vein outflow obstruction, closed a $13.5M Series A financing. Participants include Baird Venture Partners and H&Q Healthcare Investors.

Capella (Ireland) a development-stage medical device company focused on stents for bifurcation vascular disease complex coronary artery disease, cloased a $17.3M Series C financing. Participants include Fountain Healthcare Partners, Mitsui & Co., Enterprise Ireland, Polytechnos Partners and ACT Venture Capital.

Pathway Medical Technologies (Kirkland, WA) development-stage medical company focused on peripheral-arterial disease, closed a $42.5M Series D financing. Participants include HLM Venture Partners, Latterell Venture Partners, Oxford Bioscience Partners, Forbion Capital Partners, Giza Venture Capital and WRF Capital.

Concentric Medical (Mountain View, CA) a commercial-stage medical device company commercializing products for the restoration of blood flow in patients who are experiencing an ischemic stroke, closed a $15M Series D financing. Participants include New Enterprise Associates.

Tactile Systems Technology (Minneapolis, MN) developer of medical devices for the treatment of lymphedema and vascular disease, closed a $15.8M Series A financing. Participatns include Galen Partners.

Cardiva Medical (Mountain View, Calif.) medical device company focused on vascular closure, closed a $15.5M Series D financing. Participants include PTV Sciences, Galen Partners, Sycamore Ventures, Amkey Ventures, Lexli Investment, and Eminent Venture Capital.

Pathway Medical Technologies (Kirkland, WA) development-stage medical company focused on peripheral-arterial disease, closed a $24.5M Series B financing. Participants include HLM Venture Partners, Latterell Venture Partners, Oxford Bioscience Partners, Forbion Capital Partners and Giza Venture Capital.